EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isoferulic acid facilitates effective clearance of hypervirulent Klebsiella pneumoniae through targeting capsule

Tingting Wang, Huaizhi Yang, Qiushuang Sheng, Ying Ding, Jian Zhang, Feng Chen, Jianfeng Wang, Lei Song, Xuming Deng iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1012787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Tingting Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Center for Pathogen Biology and Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Severe Z…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Bacterial Capsules, Anti-Bacterial Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Interdisciplinary Integration and Innovation Project of Jilin University, Technology Development Project of Changchun City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypervirulent Klebsiella pneumoniae (hvKP) poses an alarming threat in clinical settings and global public health owing to its high pathogenicity, epidemic success and rapid development of drug resistance, especially the emergence of carbapenem-resistant lineages (CR-hvKP). With the decline of the “last resort” antibiotic class and the decreasing efficacy of first-line antibiotics, innovative alternative therapeutics are urgently needed. Capsule, an essential virulence determinant, is a major cause of the enhanced pathogenicity of hvKP and thus represents an attractive drug target to prevent the devastating clinical outcomes caused by hvKP infection. Here, we identified isoferulic acid (IFA), a natural phenolic acid compound widely present in traditional herbal medicines, as a potent broad-spectrum K . pneumoniae capsule inhibitor that suppresses capsule polysaccharide synthesis by increasing the energy status of bacteria. In this way, IFA remarkably reduced capsule thickness and impaired hypercapsule-associated hypermucoviscosity phenotype (HMV), thereby significantly sensitizing hvKP to complement-mediated bacterial killing and accelerating host cell adhesion and phagocytosis. Consequently, IFA facilitated effective bacterial clearance and thus remarkably protected mice from lethal hvKP infection, as evidenced by limited bacterial dissemination and a significant improvement in survival rate. In conclusion, this work promotes the development of a capsule-targeted alternative therapeutic strategy for the use of the promising candidate IFA as an intervention to curb hvKP infection, particularly drug-resistant cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsBacterial CapsulesAnti-Bacterial AgentsCinnamatesAnimalsMiceVirulenceHumansFemalePhagocytosis

Substanzen

Anti-Bacterial AgentsCinnamates

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Center for Pathogen Biology and Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, The First Hospital of Jilin University, C…
  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
  • Jilin Province Product Quality Supervision and Inspection Institute, Changchun, Jilin, China.

ORCID-Profile: Xuming Deng

Förderung

  • National Natural Science Foundation of China
  • Interdisciplinary Integration and Innovation Project of Jilin University
  • Technology Development Project of Changchun City
  • The Interdisciplinary Integration and Innovation Project of Jilin University
  • Technology Development Project of Changchun City 23YQ10

Zitieren

APA

Wang, T., Yang, H., Sheng, Q., Ding, Y., Zhang, J., Chen, F., Wang, J., Song, L., & Deng, X. (2025). Isoferulic acid facilitates effective clearance of hypervirulent Klebsiella pneumoniae through targeting capsule. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012787

Vancouver

Wang T, Yang H, Sheng Q, Ding Y, Zhang J, Chen F, et al. Isoferulic acid facilitates effective clearance of hypervirulent Klebsiella pneumoniae through targeting capsule. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012787

BibTeX
@article{Wang2025,
  author = {Wang, Tingting and Yang, Huaizhi and Sheng, Qiushuang and Ding, Ying and Zhang, Jian and Chen, Feng and Wang, Jianfeng and Song, Lei and Deng, Xuming},
  title = {Isoferulic acid facilitates effective clearance of hypervirulent Klebsiella pneumoniae through targeting capsule},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1012787}
}
Kostenlos starten →